Many global health professionals have dreamed about solving drug shortages, and St. Jude Children’s Research Hospital is taking the first steps toward eliminating the problem, said Carlos Rodriguez-Galindo, director of St. Jude Global.
“Through the St. Jude Global program and the WHO Global Initiative for Childhood Cancer, together with many organizations around the world, particularly the International Society of Pediatric Oncology and Childhood Cancer International, we have generated a global movement that brings governments together to address childhood cancer at a systems level,” Rodriguez-Galindo said.
In partnership with the World Health Organization, St. Jude has deployed the Global Platform for Access to Childhood Cancer Medicines, an unprecedented $200 million program aimed at getting cancer medicines to approximately 120,000 children in 50 countries.
